MRC Protein Phosphorylation and Ubiquitylation Unit, University of Dundee, Dow Street, Dundee, UK.
MRC Laboratory of Molecular Biology, Francis Crick Avenue, Cambridge, UK.
Nat Rev Mol Cell Biol. 2018 Nov;19(11):697-712. doi: 10.1038/s41580-018-0040-z.
The proteasome degrades most cellular proteins in a controlled and tightly regulated manner and thereby controls many processes, including cell cycle, transcription, signalling, trafficking and protein quality control. Proteasomal degradation is vital in all cells and organisms, and dysfunction or failure of proteasomal degradation is associated with diverse human diseases, including cancer and neurodegeneration. Target selection is an important and well-established way to control protein degradation. In addition, mounting evidence indicates that cells adjust proteasome-mediated degradation to their needs by regulating proteasome abundance through the coordinated expression of proteasome subunits and assembly chaperones. Central to the regulation of proteasome assembly is TOR complex 1 (TORC1), which is the master regulator of cell growth and stress. This Review discusses how proteasome assembly and the regulation of proteasomal degradation are integrated with cellular physiology, including the interplay between the proteasome and autophagy pathways. Understanding these mechanisms has potential implications for disease therapy, as the misregulation of proteasome function contributes to human diseases such as cancer and neurodegeneration.
蛋白酶体以受控和严格调节的方式降解大多数细胞内蛋白质,从而控制许多过程,包括细胞周期、转录、信号转导、运输和蛋白质质量控制。蛋白酶体降解在所有细胞和生物中都至关重要,蛋白酶体降解功能障碍或失效与多种人类疾病有关,包括癌症和神经退行性疾病。靶向选择是控制蛋白质降解的重要且成熟的方法。此外,越来越多的证据表明,细胞通过协调表达蛋白酶体亚基和组装伴侣来调节蛋白酶体的丰度,从而根据自身的需要来调整蛋白酶体介导的降解。蛋白酶体组装的核心是 TOR 复合物 1(TORC1),它是细胞生长和应激的主要调节剂。这篇综述讨论了蛋白酶体组装和蛋白酶体降解的调节如何与细胞生理学相整合,包括蛋白酶体和自噬途径之间的相互作用。了解这些机制可能对疾病治疗有意义,因为蛋白酶体功能的失调会导致癌症和神经退行性疾病等人类疾病。